Tag: surrogate endpoints

A Case Study Of Surrogate Outcomes For Overall Survival In The Treatment Of Chronic Myelogenous Leukemia

Exeter, UK – Ideally, licensing and value-for-money policy decisions on medications should be based on clinical trials that show benefits to final patient health outcomes, such as overall survival.  In order to speed up the approval process, however, those decisions often

Posted in Methodological Articles, Value in Health Tagged with: , , , , ,